Perrigo Company PLC (NYSE:PRGO) – Stock analysts at Svb Leerink decreased their Q4 2019 earnings per share estimates for Perrigo in a note issued to investors on Monday, May 20th. Svb Leerink analyst A. Fadia now expects that the company will earn $1.07 per share for the quarter, down from their previous estimate of $1.17. Svb Leerink also issued estimates for Perrigo’s FY2021 earnings at $4.46 EPS, FY2022 earnings at $4.60 EPS and FY2023 earnings at $4.92 EPS.
Other research analysts have also recently issued reports about the stock. Wells Fargo & Co set a $47.00 price objective on shares of Perrigo and gave the company a “hold” rating in a research note on Thursday, February 28th. Royal Bank of Canada set a $48.00 price objective on shares of Perrigo and gave the company a “hold” rating in a research note on Thursday, February 28th. SunTrust Banks initiated coverage on shares of Perrigo in a research note on Tuesday, March 19th. They issued a “hold” rating and a $51.00 price objective on the stock. ValuEngine raised shares of Perrigo from a “strong sell” rating to a “sell” rating in a research note on Wednesday, March 20th. Finally, Morgan Stanley decreased their price objective on shares of Perrigo from $67.00 to $54.00 and set an “equal weight” rating on the stock in a research note on Tuesday, March 26th. Two research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $73.00.
Shares of PRGO opened at $49.57 on Thursday. Perrigo has a 12 month low of $36.28 and a 12 month high of $80.66. The company has a market cap of $6.77 billion, a PE ratio of 10.89, a price-to-earnings-growth ratio of 2.62 and a beta of 1.29. The company has a current ratio of 1.64, a quick ratio of 1.14 and a debt-to-equity ratio of 0.48.
Perrigo (NYSE:PRGO) last announced its earnings results on Wednesday, May 8th. The company reported $1.07 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.94 by $0.13. Perrigo had a net margin of 2.43% and a return on equity of 10.40%. The company had revenue of $1.17 billion for the quarter, compared to analysts’ expectations of $1.15 billion. During the same period last year, the firm earned $1.26 earnings per share.
A number of institutional investors have recently modified their holdings of PRGO. Legal & General Group Plc boosted its position in Perrigo by 3.9% in the third quarter. Legal & General Group Plc now owns 669,602 shares of the company’s stock valued at $47,450,000 after buying an additional 25,360 shares in the last quarter. Nisa Investment Advisors LLC lifted its holdings in shares of Perrigo by 8.5% during the fourth quarter. Nisa Investment Advisors LLC now owns 30,641 shares of the company’s stock worth $1,187,000 after purchasing an additional 2,400 shares during the period. Bank of Montreal Can lifted its holdings in shares of Perrigo by 15.1% during the fourth quarter. Bank of Montreal Can now owns 230,110 shares of the company’s stock worth $8,917,000 after purchasing an additional 30,114 shares during the period. Assenagon Asset Management S.A. acquired a new position in shares of Perrigo during the fourth quarter worth $581,000. Finally, Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management lifted its holdings in shares of Perrigo by 4.8% during the fourth quarter. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management now owns 1,758,199 shares of the company’s stock worth $68,130,000 after purchasing an additional 81,000 shares during the period. Hedge funds and other institutional investors own 83.10% of the company’s stock.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 18th. Shareholders of record on Friday, May 31st will be given a $0.21 dividend. The ex-dividend date is Thursday, May 30th. This represents a $0.84 dividend on an annualized basis and a yield of 1.69%. This is a positive change from Perrigo’s previous quarterly dividend of $0.19. Perrigo’s dividend payout ratio (DPR) is currently 16.70%.
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
Featured Article: Fundamental Analysis and Individual Investors
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.